Cetera Investment Advisers
BBP icon

Cetera Investment Advisers’s Virtus Biotech ETF BBP Stock Holding History

Cetera Investment Advisers’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
16,690
+10,986
+193% +$903K ﹤0.01% 2620
2025
Q4 		$456K Buy
5,704
+813
+17% +$61.7K ﹤0.01% 3516
2025
Q3 		$342K Buy
4,891
+209
+4% +$13.7K ﹤0.01% 3724
2025
Q2 		$273K Buy
4,682
+141
+3% +$7.97K ﹤0.01% 3480
2025
Q1 		$266K Buy
4,541
+1,175
+35% +$72.1K ﹤0.01% 3375
2024
Q4 		$202K Buy
+3,366
New +$213K ﹤0.01% 3422

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MSL
MILLINGTON SECURITIES, LLC Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cetera Investment Advisers's BBP Position: Q1 2026 in Review

Cetera Investment Advisers increased its Virtus Biotech ETF (BBP) stake by 193% in Q1 2026, buying an estimated $903K and bringing the position to 16,690 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

Cetera Investment Advisers first reported a position in BBP in Q4 2024 and has held it in 6 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • Cetera Investment Advisers held 16,690 shares of Virtus Biotech ETF worth $1.39M as of Q1 2026.
  • Cetera Investment Advisers bought 10,986 Virtus Biotech ETF shares in Q1 2026, an estimated $903K.
  • Virtus Biotech ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #2620 holding.
  • Cetera Investment Advisers first reported a position in Virtus Biotech ETF in Q4 2024 and has held it in 6 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.